Skye Bioscience, Inc. Prepaid Expense and Other Assets, Current
Skye Bioscience, Inc. (SKYE) had Prepaid Expense and Other Assets, Current of $321.50 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2021-11-10
- 2021-09-30: Prepaid Expense and Other Assets, Current $321.50K.
- 2021-06-30: Prepaid Expense and Other Assets, Current $262.84K.
- 2021-03-31: Prepaid Expense and Other Assets, Current $224.61K.
- 2020-12-31: Prepaid Expense and Other Assets, Current $190.41K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2021-09-30 | $321.50K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $262.84K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $224.61K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $190.41K 10-Q · filed 2021-11-10 |
| 2014-09-30 | $79.73K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |